课题基金 / 基金详情

Core B: Liver Cell Isolation Core

Core B: Liver Cell Isolation Core
核心 B:肝细胞分离核心
批准号:
10013240
负责人:
HARTMUT W. JAESCHKE
金额:
$28.27万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2022-07-31

项目摘要

项目成果

HARTMUT W. JAESCHKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT The Liver Cell Isolation Core, formerly the Human Cell Isolation Core, is the only COBRE funded facility in the U.S. dedicated to the isolation of liver cells from humans, mice and rats. The Liver Cell Isolation Core strives to meet the following goals. 1) To provide isolated hepatocytes and specific non-parenchymal liver cells from normal and diseased human and rodent livers for the support of scientific studies, grants and publications. 2) To become a more comprehensive core by a collaborative affiliation with the University of Kansas Liver Center. 3) To establish a core lab that can operate without COBRE grant support through generation of its own revenue and through other sources of institutional and/or NIH finding. The Core operates out of a state of the art lab located on the campus of the University of Kansas Medical Center. The Core provides expert advice regarding the isolation, culture and maintenance of hepatocytes and non-parenchymal cells. The Core is under the direction of Dr. Hartmut Jaeschke and is staffed by a Core Technical Director, Mr. Kenneth Dorko, and a Core Technician, Ms. Huina Cai. For COBRE Phase III, the Liver Cell Isolation Core will expand the number of institutions from which it obtains liver specimens, increase the number of investigators that use its resources and gradually increase its service fees. These actions, coupled with additional institutional and future NIH support will allow the Core to become self-sustaining.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Liver Injury and Diseases
Mechanisms of Liver Injury and Diseases
Core A: Administrative Core
Mechanisms of Liver Injury and Diseases
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: